Pacts In Medtech, May/June 2018

Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech highlights notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we look at industry pacts that were sealed in May and June 2018.

Pacts In Medtech
Medtech industry alliances and partnerships

The digitization of health care and the technologies that enable this paradigm shift were evident among a couple of pacts that were sealed in May and June. Propeller Health partnered with Aptar Pharma, combining Aptar's know-how in device development with Propeller's experience in digital therapeutics design and implementation, to work with other pharma companies to develop digital medicines. Specifically, they focus on digital technologies for better inhaled, injectable, nasal and dermal delivery of medicines, while providing real-time patient monitoring, to enable personalized treatments. Both Aptar and Propeller have previously teamed up in 2016 to work on a connected metered dose inhaler for respiratory conditions and this most recent agreement is an expansion of their collaboration.

BioSerenity and Pierre Fabre Group have also linked up to develop a connected system of devices - based on special...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

More from Medtech Insight

Investors Urged To Prioritize Patient Engagement To Ensure Clients’ Products Succeed

 

To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.

Corify Care, Mayo Clinic Join Forces To Advance AI-Driven Global Cardiac Mapping Platform

 
• By 

Corify Care’s CEO said the company aims to submit its 510(k) application to the US FDA by year-end, targeting market clearance in 2026. The company hopes its collaboration with the Mayo Clinic will help speed adoption of ACORYS, a noninvasive mapping technology for use in complex cardiac ablations.

European Hospital Products Sourced Through ‘System That Rewards Exploitation,’ Watchdog Finds

 
• By 

While European sustainability directives CSDDD and CSRD are still in the process of adoption, environmental group Swedwatch claims the EU's procurement framework is devoid of accountability.